DNA markers predicting benefit from adjuvant fluorouracil in patients with colon cancer: a molecular study (Q44210955)

30 November 2017

DNA markers predicting benefit from adjuvant fluorouracil in patients with colon cancer: a molecular study (English)

1 reference

30 November 2017

0 references

1 reference

1 reference

C Walker

5

0 references

Philip Quirke

object named as

P Quirke

7

0 references

author name string

P L Barratt

1

1 reference

30 November 2017

M T Seymour

2

1 reference

30 November 2017

S P Stenning

3

1 reference

30 November 2017

I Georgiades

4

1 reference

30 November 2017

K Birbeck

6

1 reference

30 November 2017

UKCCCR AXIS trial collaborators. Adjuvant X-ray and Fluorouracil Infusion Study

8

1 reference

30 November 2017

language of work or name

English

0 references

publication date

1 November 2002

1 reference

30 November 2017

1 reference

30 November 2017

360

1 reference

30 November 2017

1381-1391

1 reference

30 November 2017

9343

1 reference

Comparative efficacy of adjuvant chemotherapy in patients with Dukes' B versus Dukes' C colon cancer: results from four National Surgical Adjuvant Breast and Bowel Project adjuvant studies (C-01, C-02, C-03, and C-04)

30 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911402-4

7 January 2021

Tumor marker utility grading system: a framework to evaluate clinical utility of tumor markers

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911402-4

7 January 2021

The AXIS colorectal cancer trial: randomization of over 2000 patients. The AXIS Steering Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911402-4

7 January 2021

Allelic loss of chromosome 18q and prognosis in colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911402-4

7 January 2021

Counting alleles to predict recurrence of early-stage colorectal cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911402-4

7 January 2021

Microsatellite instability and 8p allelic imbalance in stage B2 and C colorectal cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911402-4

7 January 2021

Association of tumour site and sex with survival benefit from adjuvant chemotherapy in colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911402-4

7 January 2021

Redefining the Significance of Aneuploidy in the Prognostic Assessment of Colorectal Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911402-4

7 January 2021

2000 update of recommendations for the use of tumor markers in breast and colorectal cancer: clinical practice guidelines of the American Society of Clinical Oncology

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911402-4

7 January 2021

A CA repeat 30 – 70 KB downstream from the adenomatous polyposis coli (APC) gene

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911402-4

7 January 2021

Rapid detection of allele loss in colorectal tumours using microsatellites and fluorescent DNA technology

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911402-4

7 January 2021

Allelotype of colorectal carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911402-4

7 January 2021

Cytogenetics of colorectal adenocarcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911402-4

7 January 2021

Cytogenetic aberrations in colorectal adenocarcinomas and their correlation with clinicopathologic features

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911402-4

7 January 2021

Molecular karyotype (amplotype) of metastatic colorectal cancer by unbiased arbitrarily primed PCR DNA fingerprinting

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911402-4

7 January 2021

Standardized approach for microsatellite instability detection in colorectal carcinomas.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911402-4

7 January 2021

Molecular predictors of survival after adjuvant chemotherapy for colon cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911402-4

7 January 2021

Allelic loss of chromosome 17p, mutation of the p53 gene, and microsatellite instability in right- and left-sided colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911402-4

7 January 2021

Genetic alterations during colorectal-tumor development

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911402-4

7 January 2021

Microsatellite instability in sporadic colorectal cancer is not an independent prognostic factor

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911402-4

7 January 2021

Prognostic significance of allelic lost at chromosome 18q21 for stage II colorectal cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911402-4

7 January 2021

Clinical and pathological associations with allelic loss in colorectal carcinoma [corrected].

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911402-4

7 January 2021

Mismatch repair proficiency and in vitro response to 5-fluorouracil

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911402-4

7 January 2021

Thymidylate synthase expression in colorectal cancer: a prognostic and predictive marker of benefit from adjuvant fluorouracil-based chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911402-4

7 January 2021

10.1016/S0140-6736(02)11402-4

Identifiers

DOI

1 reference

30 November 2017

1 reference